Indygeneus AI

IndyGeneUS AI is a Black-Owned & Service-Disabled Veteran-Owned genomics company creating the world’s largest blockchain-encrypted repository of indigenous and diasporic African/Afro-Latin clinical and multi-omics data for disease prevention/detection, drug discovery, and clinical disease management. Their technology integrates multi-omics, EHR data, and scientific text to build robust models for precision health equity, targeting groups historically underserved by medical science.

The company is expanding operations in Africa, especially South Africa, Ghana, and Kenya, alongside a U.S. presence. IndyGeneUS AI’s acquisition of BrainRap Artificial Intelligence leverages deep learning and contract drug manufacturing, accelerating gene target and drug discovery in precision medicine and cell & gene therapies.

Their leadership combines FDA, public health, and startup experience, and recent advisory appointments strengthen efforts to democratize genomics for global impact. The company’s mission is supported by a strategic vision to ensure that advances in genomics, precision medicine, and AI benefit all populations, particularly those historically underserved by medical science.